Product Program year 2022 Source: CMS Open Payments

Uromax Ultra

Device Gynecology

PDI 08714729341109

Open in the dashboard

General payments

$22,800

7 payments

Research payments

$0

0 payments

Through program year 2022, $22,800 in general payments and $0 in research payments were reported against Uromax Ultra (Gynecology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $13,600 6
2021 General $9,200 1

Breakdown

Who paid General payments · program years 2021–2022
  1. Boston Scientific Corporation $22,800 7 payments
Top recipients General payments · program year 2022
  1. Paul Chung Urology · Philadelphia, PA $4,000 29% · 1 payment
  2. Matthew Katz Urology · New York, NY $4,000 29% · 1 payment
  3. Daniel Sagalovich Urology · Staten Island, NY $2,800 21% · 1 payment
  4. Wilson Molina Urology · Kansas City, KS $2,000 15% · 1 payment
  5. Travis Pagliara Urology · Minneapolis, MN $400 3% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Urology $13,600 100% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. New York $6,800 50% · 2 recipients
  2. New Jersey $4,000 29% · 1 recipient
  3. Missouri $2,000 15% · 1 recipient
  4. Florida $400 3% · 1 recipient
  5. Minnesota $400 3% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

7 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record